Rephonic
Artwork for Unraveling Cancer

Unraveling Cancer

Patient Power
Chronic Lymphocytic Leukemia
Systemic Mastocytosis
Mantle Cell Lymphoma
Cancer-Related Fatigue
Clinical Trials
Dermatology
Patient Advocacy
Skin Cancer
Venetoclax
BTK Inhibitors
Education
Obinutuzumab
Chemotherapy
Patient Care
Comorbidities
Allergy
Bone Marrow Biopsy
Patient-Centered Care
Mental Health
Immune-Based Therapy

Join us for the Unraveling Cancer Podcast Series where we explore stories and news about living with cancer, the latest research from conferences, and patient advocate stories. Our patient hosts are joined by leaders in the field; from researchers working on the treatments of tomorrow, to holistic practitioners and mental health professionals.Patient Power® is a leader in supporting patients with ... more

PublishesMonthlyEpisodes19Founded2 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for Unraveling Cancer

Latest Episodes

As a 16-year CLL patient himself, Brad brings a personal perspective as Dr. Rogers explains

what fixed duration treatment means, which drug combinations are currently approved, and

what the ramp-up process looks like, including why close monitoring... more

In this episode of the Patient Power podcast, Unraveling Cancer, patient host Brad

Adams is joined by Paul J. Hampel, MD, a hematologist-oncologist at Mayo Clinic in Rochester,

for a conversation about fixed duration versus continuous treatment for... more

In this episode of the Patient Power podcast, Unraveling Cancer, patient host Michele Nadeem-Baker is joined by Thomas Kipps, MD, PhD, UC San Diego, for a conversation about the latest immune-based advances in chronic lymphocytic leukemia (CLL), incl... more

Patient advocate, Michele Nadeem Baker, hosts Boyu Hu, MD, Director of Lymphoma and Chronic Lymphocytic Leukemia at the Huntsman Cancer Institute at the University of Utah for a discussion on fixed duration treatment.

Physician assistant Jill Miller shares what CLL patients really need to know about fixed-duration treatment. Learn how to manage side effects, what to expect month by month, when treatment ends, and how to navigate the emotional transition from activ... more

In this episode of Patient Power’s podcast Unraveling Cancer, patient host Michele Nadeem-Baker speaks with Daniel Ermann, MD, Huntsman Cancer Institute, about how combination therapies are revolutionizing treatment for chronic lymphocytic leukemia. ... more

In this episode of Patient Power’s podcast Unraveling Cancer, patient host

Michele Nadeem-Baker sits down with Lucy Potter, MD, MPH, MD Anderson,

for a conversation about one of the most common challenges in cancer care:

fatigue. They explore prac... more

In this episode of the Patient Power podcast, Unraveling Cancer, patient host, Michele Nadeem-Baker is joined by Deborah Stephens, DO, UNC at Chapel Hill, for a conversation about choosing a treatment for CLL, when to consider a clinical trial and th... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Dr. Kerry Rogers
Assistant Professor, Division of Hematology, Ohio State University
Ohio State University
Episode: Your Guide to Starting and Stopping CLL Treatment
Dr. Paul Hampel
CLL specialist
Mayo Clinic
Episode: Fixed vs. Continuous CLL Treatment Explained
Thomas Kipps
World-renowned CLL specialist
Moores Cancer Center, UC San Diego
Episode: New Immune Advances in CLL
Jill Miller
Physician assistant from MD Anderson
MD Anderson
Episode: From Diagnosis to Treatment End: Navigating Fixed-Duration Therapy for CLL
Michelle Nadine Baker
Medical reporter and someone living with CLL
Unraveling Cancer Podcast
Episode: From Diagnosis to Treatment End: Navigating Fixed-Duration Therapy for CLL
Daniel Ermann
Physician-scientist from Huntsman Cancer Institute
Huntsman Cancer Institute
Episode: Functional Cure? The Promise of CLL Combination Therapy
Dr. Lucy Potter
Medical doctor with a Master's in Public Health at MD Anderson's Division of Internal Medicine Fatigue Clinic
MD Anderson Cancer Center
Episode: Strategies to Combat Fatigue
Dr. Benjamin Heyman
Associate Clinical Professor at University of California, San Diego
University of California, San Diego
Episode: Unraveling Cancer: Frontline Therapies for Mantle Cell Lymphoma
Dr. Lauren Madigan
Assistant professor of dermatology and expert in mastocytosis
University of Utah, Huntsman Cancer Institute
Episode: SM and Skin: A Dermatologist Explains What’s Going On

Host

Michele Nadeem-Baker
Medical journalist and CLL patient who frequently discusses fixed-duration therapy, patient experience, and research directions.

Talking Points

Recent interactions between the hosts and their guests.

Your Guide to Starting and Stopping CLL Treatment
Q: What about the monitoring burden for fixed-duration versus continuous therapy once you pass the initial ramp-ups?
Monitoring for fixed-duration regimens varies by regimen; some require monthly visits for antibody infusions in the initial phase, but after that many patients are seen every three to four months, similar to continuous BTK inhibitor therapy.
Your Guide to Starting and Stopping CLL Treatment
Q: Let me make sure we understand fixed-duration. What I'm talking about here is going into treatment for a certain number of years or months, and then you stop treatment versus continuous where you're on the drug, really for the rest of your life. Is that fair?
Yes. Fixed-duration regimens have a defined start and stop, unlike continuous therapy which continues until there is a reason to stop, such as progression or intolerable side effects.
Fixed vs. Continuous CLL Treatment Explained
Q: What are the advantages of fixed-duration therapy versus continuous BTK inhibitor therapy?
Fixed-duration regimens consolidate treatment into a defined timeframe, potentially reducing long-term exposure and cumulative toxicity, but they require more upfront monitoring and logistics during the active treatment phase. Continuous BTK inhibitors offer ongoing disease control with simpler ongoing follow-up, but patients stay on therapy longer and face long-term tolerability and adherence considerations.
New Immune Advances in CLL
Q: How do vaccines fit into the management of CLL, and what should patients expect in terms of vaccine effectiveness and safety?
Vaccines can elicit protective immune responses in patients with CLL, though responses may vary; both antibody and cellular responses (including T cell activity) contribute to protection, and clinicians weigh risks and benefits, monitor reactions, and advocate for vaccination while considering individual exposure and risk.
New Immune Advances in CLL
Q: What is the significance of immune-based research for CLL patients, and how does it translate into clinical benefit?
Immune-based therapies—such as antibody therapies targeting CD20—have transformed CLL by providing deeper remissions and better disease control, with strategies that can engage either passive antibody support or enable active immune responses depending on patient fitness.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Unraveling Cancer

What is Unraveling Cancer about and what kind of topics does it cover?

The series centers on living with cancer through patient-led perspectives, practical guidance, and the latest research updates. Episodes frequently tackle treatment decisions, fixed-duration versus continuous therapies, and the impact of novel targeted treatments on quality of life. A recurring emphasis is on patient experience, side effect management, and navigating the healthcare system, with guest physicians and researchers offering context on emerging therapies, clinical trials, and real-world considerations for patients and caregivers. The show stands out for its blend of medical insight and personal storytelling, aiming to empower listeners with information while highlighting the human side of cancer care.

Where can I find podcast stats for Unraveling Cancer?

Rephonic provides a wide range of podcast stats for Unraveling Cancer. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Unraveling Cancer and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Unraveling Cancer get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Unraveling Cancer, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Unraveling Cancer?

Rephonic provides comprehensive predictive audience data for Unraveling Cancer, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Unraveling Cancer have?

To see how many followers or subscribers Unraveling Cancer has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Unraveling Cancer?

These podcasts share a similar audience with Unraveling Cancer:

1. The Daily
2. Health News Today | 2 Min News | The Daily News Now!

How many episodes of Unraveling Cancer are there?

Unraveling Cancer launched 2 years ago and published 19 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Unraveling Cancer?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Unraveling Cancer?

Rephonic pulls ratings and reviews for Unraveling Cancer from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Unraveling Cancer?

Rephonic provides full transcripts for episodes of Unraveling Cancer. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Unraveling Cancer?

Recent guests on Unraveling Cancer include:

1. Dr. Kerry Rogers
2. Dr. Paul Hampel
3. Thomas Kipps
4. Jill Miller
5. Michelle Nadine Baker
6. Daniel Ermann
7. Dr. Lucy Potter
8. Dr. Benjamin Heyman

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days